Advertisement

FDA OKs 1st Generic Version of Popular Advair Asthma Inhaler

FDA OKs 1st Generic Version of Popular Advair Asthma Inhaler

LINDA A. JOHNSON, AP Medical Writer
Created: January 31, 2019 02:03 PM

The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators.

Advertisement – Content Continues Below

The Food and Drug Administration on Wednesday approved Mylan's version in three strengths for ages 4 and up.

The inhalers are used twice daily to keep airways open and prevent flare-ups of wheezing, shortness of breath and other symptoms of asthma or chronic obstructive pulmonary disease. About 42 million Americans have those conditions.

The device contains two medicines, inhaled in a precise mixture. That complexity has stymied a couple of other companies developing generic versions of GlaxoSmithKline's Advair Diskus inhaler, which costs about $400 a month.

Generics generally are cheaper. Mylan didn't immediately respond to queries about when its inhaler, called Wixela Inhub, will be available or what the price will be.

Credits

LINDA A. JOHNSON, AP Medical Writer

Copyright 2019 The Associated Press. All rights reserved.

Advertisement
Advertisement
Relay Media Amp

Pres. Trump Declares National Emergency to Get Funding for Border Wall

3 Dead, Deputy Injured in North-Central Minn. Shooting

An "Old Fashioned Winter" is Making Snow Removal Tough

Sheriff: Man Accidentally Fires Gun Inside Ironwood Walmart

Roses, Step Aside: UMD Puts Orchid Collection on Display

Northlanders Celebrate V-Day with Unique, Loving Traditions

Advertisement